Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsiaVictoria P. Tan, Wai K. Leung, Ivan Fan‐Ngai Hung et al.|Alimentary Pharmacology & Therapeutics|2017Cited by 141
Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancerWenqing Zhang, Benjamin C.Y. Wong, Claude Sardet et al.|Carcinogenesis|2010Cited by 69
XIAP‐associated factor 1 (XAF1), a novel target of p53, enhances p53‐mediated apoptosis via post‐translational modificationBing Zou, Benjamin C.Y. Wong, Chor Sang Chim et al.|Molecular Carcinogenesis|2011Cited by 52
Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1Benjamin Wong, Jide Wang, Bing Zou et al.|European Journal of Cancer|2010Cited by 42
Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancerJuan Ma, Benjamin C.Y. Wong, Ivan Fan‐Ngai Hung et al.|Carcinogenesis|2010Cited by 31